Please enable JavaScript.
Coggle requires JavaScript to display documents.
urothelial cancer - Coggle Diagram
urothelial cancer
-
metastatic disease
cisplatin
eligibility ~50% pts
PS ECOG 0-1, CrCl >=60ml/min, no hearing loss, <G2 PN, <G3 NYHA HF
-
2nd line
enfortumab (ADC), erdafitinib (FGFR inhibitor)
-
-